Claudio Semeraro

As clinical development timelines accelerate and supply chains become increasingly complex, the traditional separation between clinical and commercial supply strategies is proving ever more inefficient. This session will explore how integrating commercial materials and commercial-ready supply strategies into clinical trials can create smarter, more agile supply chains that are better prepared for launch.

UCB will open the session by sharing its current work and practical experience of leveraging commercial material within clinical trials, particularly in late-stage and pivotal studies. The discussion will focus on how organisations can move away from producing clinical-only material and instead adopt smarter, more connected supply strategies that improve inventory management, optimise capacity and reduce waste.

Beyond operational efficiency, the session will highlight the importance of viewing clinical trials as a critical step in preparing for future commercialisation. Topics will include early alignment with commercial colleagues, the introduction of commercial vendors and clinical trial supply partners during Phase III, and the identification of synergies that enable a seamless transition from clinical supply to commercial launch.

Following UCB’s perspective, the session will open to the room for a conference-wide discussion, inviting other pharmaceutical companies to share their experiences, challenges and lessons learned.

Key Discussion Themes

• Using commercial material in clinical trials to improve supply efficiency and inventory management
• Aligning clinical and commercial supply strategies earlier in development
• Organisational and change-management considerations for implementing smarter supply strategies